Tarroza, Rhick Shan P.
HRN: 28-87-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CEFAZOLIN 1GM (VIAL)
04/20/2026
04/21/2026
IV
1gm
OCTOR
Talonavicular Dislocation Sec To RCI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: